Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
NAT6 (human)
p Phosphorylation
ac Acetylation
me Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
ub Ubiquitination
sm Sumoylation
ne Neddylation
gl O-GlcNAc
ga O-GalNAc
pa Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage
sc Succinylation

Overview
NAT6 Seems to be involved in N-acetylation. Acts on peptides with a N-terminal Met followed by Asp/Glu/Asn. May act as a tumor suppressor. Belongs to the acetyltransferase family. 2 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Amino Acid Metabolism - tyrosine; EC 2.3.1.-; Lipid Metabolism - glycerophospholipid; Acetyltransferase; Secondary Metabolites Metabolism - limonene and pinene degradation; Amino Acid Metabolism - phenylalanine
Cellular Component: cytoplasm
Molecular Function: N-acetyltransferase activity
Biological Process: metabolic process
Reference #:  Q93015 (UniProtKB)
Alt. Names/Synonyms: FUS-2; FUS2; N-acetyltransferase 6; N-acetyltransferase 6 (GCN5-related); NAT6; Protein fus-2; Protein fusion-2; putative tumor suppressor
Gene Symbols: NAT6
Molecular weight: 31,445 Da
Basal Isoelectric point: 7.75  Predict pI for various phosphorylation states
Select Structure to View Below

NAT6

Protein Structure Not Found.


STRING  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  ENZYME  |  Phospho.ELM  |  NetworKIN  |  UniProtKB  |  Entrez-Gene  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

► Hide Isoforms
 
0 1 - gap
0 1 T7-p _MELILStSPAELTL
0 1 S8 MELILStSPAELTLD
0 1 - gap
0 3 - gap
0 1 T207 TSRRLPATLLNAFPT
0 7 S217-p NAFPTAPsPRPPRKA
0 1 S254-p LPECLTIsPPVPSGP
0 5 Y271-p KSLLETQyQNVRGRP
0 1 R275 ETQyQNVRGRPIFWM
  NAT6 iso2  
T14-p SPGPAKLtPTLDPTH
T29 RMELILSTSPAELTL
S30 MELILSTSPAELTLD
- gap
- gap
T229 TSRRLPATLLNAFPT
S239 NAFPTAPSPRPPRKA
S276 LPECLTISPPVPSGP
Y293 KSLLETQYQNVRGRP
R297 ETQYQNVRGRPIFWM
  mouse

 
- gap
T7 _MELILSTsPAKLTL
S8-p MELILSTsPAKLTLD
S44-p RQPELSLsPRLAELT
S233-p AFTNRRLsTtVLRAF
T235-p TNRRLsTtVLRAFSK
C245 RAFSKPPCPQPPCKE
S282 LPQSLTASPPPSPEP
Y299 QSPLETCYRDLkGCP
K303-ac ETCYRDLkGCPIFWM
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.